Ramirez B and Richter JE |
Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. |
1993 |
Aliment. Pharmacol. Ther. |
pmid:8094981
|
Catnach SM et al. |
Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. |
1993 |
Aliment. Pharmacol. Ther. |
pmid:8439638
|
Verhagen MA et al. |
Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663833
|
Haans JJ and Masclee AA |
Review article: The diagnosis and management of gastroparesis. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:18081647
|
Netzer P et al. |
Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12182748
|
Athanasakis E et al. |
Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12182757
|
McCallum RW and Cynshi O |
Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:17894654
|
Chen CL et al. |
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11929393
|
Winstead NS and Wilcox CM |
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:17848180
|
Annese V et al. |
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9218089
|
van Erpecum KJ et al. |
Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10903008
|
Chiba T et al. |
Motilides accelerate regional gastrointestinal transit in the dog. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10886053
|
Landry C et al. |
Could oral erythromycin optimize high energy continuous enteral nutrition? |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971296
|
Ehrenpreis ED et al. |
Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9690728
|
Jameson JS et al. |
Oral or intravenous erythromycin has no effect on human distal colonic motility. |
1992 |
Aliment. Pharmacol. Ther. |
pmid:1420750
|
Curry JI et al. |
Review article: erythromycin as a prokinetic agent in infants and children. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11328252
|
Boecxstaens V et al. |
Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21517922
|
Laine L et al. |
Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791949
|
Wehrmann T et al. |
Effect of erythromycin on human biliary motility. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791972
|
Mosonyi L et al. |
[Infectious and neoplastic complications in rheumatoid arthritis]. |
1974-1975 |
Allerg Immunol (Leipz) |
pmid:4282826
|
Sabbah A et al. |
[Cell-mediated immunity in antibiotic therapy]. |
1988 |
Allerg Immunol (Paris) |
pmid:3401307
|
Sabbah A |
[Teldane update. Interview with Dr. Alfred Sabbah, chief of the immuno-allergology laboratory of the C.H.U. d'Angers. Interview by Dr. Pierre Ceddaha]. |
1993 |
Allerg Immunol (Paris) |
pmid:8466639
|
Wessel F |
[Peri-anesthesia allergies to antibiotics]. |
1998 |
Allerg Immunol (Paris) |
pmid:9684043
|
López Serrano C et al. |
Urticaria from erythromycin. |
1993 Nov-Dec |
Allergol Immunopathol (Madr) |
pmid:7512783
|
San Pedro de Saenz B et al. |
FDE to macrolides. |
2002 |
Allergy |
pmid:11991294
|
Florido Lopez JF et al. |
Fixed eruption due to erythromycin. A case report. |
1991 |
Allergy |
pmid:1826819
|
Adamson L and Walum E |
Insulin and IGF-1 mediated inhibition of apoptosis in CHO cells grown in suspension in a protein-free medium. |
2007 |
Altern Lab Anim |
pmid:17650954
|
Asnes RS and Grebin B |
Practical antibiotic therapy in children. |
1973 |
Am Fam Physician |
pmid:4546004
|
Snydman DR |
Campylobacter Gastroenteritis. |
1982 |
Am Fam Physician |
pmid:7055019
|
Miller KE |
Diagnosis and treatment of Chlamydia trachomatis infection. |
2006 |
Am Fam Physician |
pmid:16669564
|
McSherry JA |
Mycoplasma pneumoniae infections. |
1983 |
Am Fam Physician |
pmid:6837403
|
Guckian JC |
Complications of antimicrobial therapy. |
1973 |
Am Fam Physician |
pmid:4353071
|
Pagano JS and Sarubbi FA |
Pneumonia. |
1972 |
Am Fam Physician |
pmid:4642154
|
Langer R and Binnick S |
Treatment of acne vulgaris. |
1979 |
Am Fam Physician |
pmid:157066
|
Raz R and Bitnun S |
Dilemmas of streptococcal pharyngitis. |
1987 |
Am Fam Physician |
pmid:3105301
|
Stott GA |
New macrolide antibiotics: clarithromycin and azithromycin. |
1992 |
Am Fam Physician |
pmid:1325106
|
Constantine PA |
Antibiotic therapy and serum digoxin toxicity. |
1998 |
Am Fam Physician |
pmid:9531908
|
Robinson M |
Prokinetic therapy for gastroesophageal reflux disease. |
1995 |
Am Fam Physician |
pmid:7653432
|
Derrick CW and Dillon HC |
Impetigo contagiosa. |
1971 |
Am Fam Physician |
pmid:5000340
|
Winkelman L |
Recommended revision to endocarditis prophylaxis. |
1991 |
Am Fam Physician |
pmid:1950954
|
Kiselica D |
Group A beta-hemolytic streptococcal pharyngitis: current clinical concepts. |
1994 |
Am Fam Physician |
pmid:8154403
|
|
Syphilis--recommended treatment schedules, 1976. |
1976 |
Am Fam Physician |
pmid:961559
|
Luft FC |
Antimicrobials in kidney and liver failure. |
1976 |
Am Fam Physician |
pmid:941822
|
Ackley AM |
Legionnaires' disease: an update. |
1981 |
Am Fam Physician |
pmid:7020390
|
Johnson WT |
Managing odontogenic infections. |
1984 |
Am Fam Physician |
pmid:6731235
|
|
Gonorrhea--recommended treatment schecules, 1974. |
1975 |
Am Fam Physician |
pmid:123699
|
Culp ER |
Ilosone update. |
1980 |
Am Fam Physician |
pmid:7377065
|
|
Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. |
2012 |
Am Fam Physician |
pmid:22335221
|
Tan HH |
Antibacterial therapy for acne: a guide to selection and use of systemic agents. |
2003 |
Am J Clin Dermatol |
pmid:12688836
|
Taylor GA and Shalita AR |
Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. |
2004 |
Am J Clin Dermatol |
pmid:15301572
|
Ferguson DL et al. |
Lichenoid lymphocytic vasculitis with a high component of histiocytes. Histogenetic implications in a specified clinical setting. |
1989 |
Am J Dermatopathol |
pmid:2729528
|
Rosen RA |
The use of antibiotics in the initial management of recent dog-bite wounds. |
1985 |
Am J Emerg Med |
pmid:3970747
|
Altieri M et al. |
Antibiotic prophylaxis in intraoral wounds. |
1986 |
Am J Emerg Med |
pmid:3096345
|
Paris DG et al. |
Torsades de pointes induced by erythromycin and terfenadine. |
1994 |
Am J Emerg Med |
pmid:7945604
|
Traub SJ et al. |
Use of pharmaceutical promotility agents in the treatment of body packers. |
2003 |
Am J Emerg Med |
pmid:14574669
|
Parker DL et al. |
Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin. |
2010 |
Am J Health Syst Pharm |
pmid:20044367
|
Howard KB et al. |
Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. |
1999 |
Am J Health Syst Pharm |
pmid:10478989
|
|
Erythromycin resistance in Finland declines after reduction in macrolide use. |
1997 |
Am J Health Syst Pharm |
pmid:9359947
|
Lestico MR and Smith AD |
Stevens-Johnson syndrome following erythromycin administration. |
1995 |
Am J Health Syst Pharm |
pmid:8528839
|
Horn JR |
Analysis of purported erythromycin-warfarin interaction. |
2010 |
Am J Health Syst Pharm |
pmid:20516463
|
David LM |
Phlebitis with intravenous erythromycin. |
1987 |
Am J Hosp Pharm |
pmid:3578303
|
Pluta PL and Morgan PK |
Stability of erythromycin in intravenous admixtures. |
1986 |
Am J Hosp Pharm |
pmid:3799601
|
Meade RH |
Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of erythromycin and its derivatives. |
1979 |
Am J Hosp Pharm |
pmid:386785
|
Pinchiera JC et al. |
Effect of bariatric surgery on erythromycin absorption. |
1981 |
Am J Hosp Pharm |
pmid:7211889
|
Dombrower P |
Intravenous erythromycin dosages. |
1979 |
Am J Hosp Pharm |
pmid:525638
|
Williams KG |
Pharmacists' duty to warn of drug interactions. Dooley v. Everett. |
1992 |
Am J Hosp Pharm |
pmid:1471651
|
Garrison TJ and Kleinschmidt M |
Other views on erythromycin selection. |
1981 |
Am J Hosp Pharm |
pmid:7258211
|
Kistler SB and Kough RH |
Antibiotic acquistions in a 387-bed general hospital during 1960, 1965, 1967 and 1968. |
1969 |
Am J Hosp Pharm |
pmid:4313068
|
Higgin CR and Mazur MS |
Prepacking unit dose erythromycin ophthalmic ointment. |
1984 |
Am J Hosp Pharm |
pmid:6465146
|
Bergstrom RF and Fites AL |
Letter: Stability of erythromycin gluceptate in sodium chloride injection and dextrose injection. |
1975 |
Am J Hosp Pharm |
pmid:237418
|
LeBel M |
Risk-benefit equation for erythromycin estolate. |
1980 |
Am J Hosp Pharm |
pmid:7361788
|
O'Brien TE |
Excretion of drugs in human milk. |
1974 |
Am J Hosp Pharm |
pmid:4608122
|
WEISS E and DRESSLER HR |
Selection of an erythromycin-resistant strain of Rickettsia prowazekii. |
1960 |
Am J Hyg |
pmid:13843711
|
Lee WS |
Disc sentitivity as a diagnostic aid in the identification of group D enterococci. |
1972 |
Am J Med Technol |
pmid:4490310
|
Hansen JL and Swanson LN |
Case study: Drug interference in clinical chemistry. |
1981 |
Am J Med Technol |
pmid:7223765
|
Bauer AW |
The decline of antibiotic resistance of Staphylococcus aureus isolated in the community. |
1971 |
Am J Med Technol |
pmid:5206836
|
Dietz CC et al. |
Double-gradient plate susceptibility testing of an Enterococcus and its L-form. |
1973 |
Am J Med Technol |
pmid:4701052
|
Lilley LL and Guanci R |
Drug interaction triggers weakness. |
1998 |
Am J Nurs |
pmid:9556673
|
|
New antibiotics look good against M. avium. |
1992 |
Am J Nurs |
pmid:1309625
|
Devereux PM and Goldstein EJ |
Legionnaires' disease: finding answers to the riddle. |
1980 |
Am J Nurs |
pmid:6898101
|
|
Erythromycin use linked to pyloric stenosis. |
2000 |
Am J Nurs |
pmid:10738394
|
Koegel L |
Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum. |
1985 |
Am J Otol |
pmid:3872601
|
Sacristán JA et al. |
Ototoxicity of erythromycin in man: electrophysiologic approach. |
1993 |
Am J Otol |
pmid:8503495
|
Kyrmizakis DE et al. |
QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin. |
2002 Sep-Oct |
Am J Otolaryngol |
pmid:12239699
|
Ghidini A et al. |
Successful outcome after antibiotic treatment of postamniocentesis membrane rupture and chorioamnionitis in multiple pregnancy. |
1999 |
Am J Perinatol |
pmid:10772199
|
Bar J et al. |
Effect of antibiotic therapy in preterm premature rupture of the membranes on neonatal mortality and morbidity. |
2000 |
Am J Perinatol |
pmid:11110340
|
Ogasawara KK and Goodwin TM |
The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum. |
1997 |
Am J Perinatol |
pmid:9259934
|
El Younis CM et al. |
Rapid marked response of severe hyperemesis gravidarum to oral erythromycin. |
1998 |
Am J Perinatol |
pmid:9890250
|
Crum NF et al. |
Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. |
2003 |
Am J Prev Med |
pmid:12880877
|
Usiskin SI et al. |
Retreatment with clozapine after erythromycin-induced neutropenia. |
2000 |
Am J Psychiatry |
pmid:10831491
|
Funderburg LG et al. |
Seizure following addition of erythromycin to clozapine treatment. |
1994 |
Am J Psychiatry |
pmid:7977898
|
Fox KK et al. |
Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. |
2001 |
Am J Public Health |
pmid:11392941
|
Tsevat J et al. |
Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. |
1989 |
Am J Public Health |
pmid:2499200
|
Park HH et al. |
The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. |
2010 Sep-Oct |
Am J Rhinol Allergy |
pmid:21244734
|
Jiang RS et al. |
Efficacy of Chinese herbal medicine compared with a macrolide in the treatment of chronic rhinosinusitis without nasal polyps. |
2012 Jul-Aug |
Am J Rhinol Allergy |
pmid:22801017
|
RUBIN A et al. |
The effects of the administration of erythromycin upon Neisseria gonorrhoeae and pleuropneumonia-like organisms in the uterine cervix. |
1954 |
Am J Syph Gonorrhea Vener Dis |
pmid:13189043
|
GABLE GR et al. |
Treatment of gonorrhea with erythromycin. |
1953 |
Am J Syph Gonorrhea Vener Dis |
pmid:13065617
|
ALEXANDER LJ and SCHOCH AG |
Erythromycin in venereal diseases. |
1954 |
Am J Syph Gonorrhea Vener Dis |
pmid:13138815
|
MANNING PR et al. |
Erythromycin in the treatment of gonorrhea. |
1954 |
Am J Syph Gonorrhea Vener Dis |
pmid:13138816
|
Sikri V et al. |
Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux. |
2004 Nov-Dec |
Am J Ther |
pmid:15543082
|